Discover
TNXP
Tonix Pharmaceuticals Holding Corp.
11.56
1 x 11.11
1 x 11.53
bid
ask
+
0.00
0.00%
1 @ 09:18 AM
11.37 -0.19 (1.65%)
| Ytd | -25.99% | |
| 1y | -74.17% |
day range
10.03
52 week range
69.97
| Open | Prev Close | 11.56 | Low | High | Mkt Cap | 184.28M | |||
| Vol | 0.00 | Avg Vol | 507.14K | EPS | -14.36 | P/E | -0.81 | Forward P/E | -0.01 |
| Beta | 1.64 | Short Ratio | 0.35 | Inst. Own | 0.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 12.46 | 200-d Avg | 15.32 | 1yr Est | 5.83 |
| Income Statement | |||
| Total Revenue | 6.88M | ||
| Revenues (USD) | 6.88M | ||
| Cost of Revenue | 1.58M | ||
| Gross Profit | 5.30M | ||
| Operating Expenses | 46.84M | ||
| Research and Development Expense | 18.21M | ||
| Selling, General and Administrative Expense | 28.62M | ||
| Operating Income | -41.54M | ||
| Net Income | -40.19M | ||
| Net Income Common Stock | -40.19M | ||
| Net Income Common Stock (USD) | -40.19M | ||
| Consolidated Income | -40.19M | ||
| Earnings per Basic Share | -2.93 | ||
| Earnings per Basic Share (USD) | -2.93 | ||
| Earnings per Diluted Share | -2.93 | ||
| Earning Before Interest & Taxes (EBIT) | -40.19M | ||
| Earning Before Interest & Taxes (USD) | -40.19M | ||
| Weighted Average Shares | 13.71M | ||
| Weighted Average Shares Diluted | 13.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 185.47M | ||
| Cash and Equivalents (USD) | 185.47M | ||
| Trade and Non-Trade Receivables | 8.82M | ||
| Current Assets | 207.17M | ||
| Property, Plant & Equipment Net | 46.34M | ||
| Total Assets | 257.91M | ||
| Debt Current | 162.00K | ||
| Total Debt | 1.29M | ||
| Current Liabilities | 29.65M | ||
| Debt Non-Current | 1.13M | ||
| Total Liabilities | 30.78M | ||
| Accumulated Retained Earnings (Deficit) | -894.91M | ||
| Accumulated Other Comprehensive Income | -283.00K | ||
| Shareholders Equity | 227.14M | ||
| Shareholders Equity (USD) | 227.14M | ||
| Assets Non-Current | 50.74M | ||
| Total Debt (USD) | 1.29M | ||
| Goodwill and Intangible Assets | 120.00K | ||
| Inventory | 3.65M | ||
| Liabilities Non-Current | 1.13M | ||
| Trade and Non-Trade Payables | 9.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 555.00K | ||
| Net Cash Flow from Financing | 20.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.80M | ||
| Capital Expenditure | -1.69M | ||
| Issuance (Purchase) of Equity Shares | 20.20M | ||
| Net Cash Flow from Investing | -1.69M | ||
| Net Cash Flow from Operations | -42.32M | ||
| Effect of Exchange Rate Changes on Cash | 6.00K | ||
| Share Based Compensation | 1.97M | ||